• Maplight Therapeutics General Counsel Kristopher L. Hanson reported sales of 13,917 shares of voting common stock on May 11, 2026.
• Sales were reported at weighted average prices ranging from $27.61 to $30.56.
• Hanson’s direct holding fell to 162,331 shares following transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001789970-26-000010), on May 11, 2026, and is solely responsible for the information contained therein.